To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

January 3, 2023

Study Completion Date

April 14, 2023

Conditions
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
Interventions
DRUG

Paclitaxel

Chemotherapy plus HER2 Blockade

DRUG

Trastuzumab

Chemotherapy plus HER2 Blockade

DRUG

Pertuzumab

Chemotherapy plus HER2 Blockade

DRUG

Palbociclib

CDK Inhibition plus Hormonal Therapy plus HER2 Blockade

DRUG

Letrozole

CDK Inhibition plus Hormonal Therapy plus HER2 Blockade

DRUG

Trastuzumab

CDK Inhibition plus Hormonal Therapy plus HER2 Blockade

DRUG

Pertuzumab

CDK Inhibition plus Hormonal Therapy plus HER2 Blockade

Trial Locations (54)

1000

Jules Bordet Institute, Brussels

1708

HFR Freiburg - Kantonsspital, Fribourg

2930

AZ Klina, Augustijinslei 100, Brasschaat

4000

CHR de la Citadelle, Boulevard du XIIe de Ligne, 1, Liège

Clinique Saint- Joseph, Rue de Hesbaye 75, Liège

4031

Universitatsspital Basel, Petersgraben 4, Basel

5000

Clinique Saint Elizabeth, Place Louise Godin 15, Namur

5400

Kantonsspital Baden AG, Baden

6500

Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, IOSI, Bellinzona

8008

Brust-Zentrum AG, Seefeldstrasse 214, Zurich

8091

University Hospital Zurich, Frauenklinikstrasse 10, Zurich

8401

Kantonsspital Winterthur, Winterthur

8501

Brustzentrum Thurgau / Kantonsspital Frauenfeld, Pfaffenholzstrasse 4, Frauenfeld

9007

Kantonsspital St. Gallen, Rorschacher Strasse 95, Sankt Gallen

9100

AZ Nikolaas, Moerlandstrat 1, Sint-Niklaas

15121

"ASO SS Antonio e Biagio Cesare Arrigo, Via Venezia 16", Alessandria

16128

E.O. Ospedali Galliera, Mura delle Cappuccine, 14, Genova

16132

Ospedale Policlinico San Martino,Largo Rosanna Benzi,10, Genova

20141

Milano, IEO, Via Ripamonti 435, Milan

21100

AO Universitaria Ospedale Di Circolo e Fondazione,v.le L. Borri, 57, Varese

23900

Ospedale Civile di Lecco,Via della Filanda 14, Lecco

24127

Ospedali Riuniti di Bergamo, A.O.Papa Giovanni XXIII, Piazza OMS1, Bergamo

25123

ASST Spedali Civili Brescia, Piazzale Spedali Civili n.1, Brescia

27100

Istituti Clinici Scientifici Maugeri SpA-SB,Via Salvatore Maugeri N° 10, Pavia

28100

Università del Piemonte Orientale - SCDU Oncologia, Corso Mazzini 18, Novara

33081

Centro di Riferimento Oncologico (CRO), Via Franco Gallini 2, Aviano

33100

Azienda Ospedaliero-Universitaria di Udine, Piazzale S.M. Misericordia 15, Udine

39100

Comprensorio Sanitario Bolzano, Via Lorenz Bohler, 5, Bolzano

40138

Ospedale S. Orsola-Malpighi, Viale Ercolani 4/2, Bologna

41012

U.O Medicina Oncologica Ospedale di Carpi, Via G. Molinari, 2, Carpi

43126

Azienda Ospedaliero-Universitaria di Parma, via Gramsci 14, Parma

47014

Istituto scientifico Romagnolo per lo studio e la cura,Via Piero Maroncelli 40, Meldola

47037

UO Oncologia, Rimini Hospital, Via Settembrini 2, Rimini

48121

Santa Maria delle Croci Hospital, Viale Randi 5, Ravenna

56125

A.O. Universitaria Pisana Ospedale Santa Chiara Pisa, Via Roma 67, Pisa

59100

Hospital of Prato, Via Dolce dei Mazzamuti, 7, Prato

60020

Clinica Oncologica-Ospedali Riuniti Ancona, Via Conca n.71,, Torrette

92210

Institut Curie - Site Saint Cloud, Saint-Cloud

Unknown

Institut Sainte Catherine, Avignon

Institut Bergonié, Bordeaux

Centre Hospitalier Le Mans, Le Mans

Centre Léon Berard, Lyon

ICM Val d'Aurelle, Montpellier

Institut de Cancérologie de l'Ouest (ICO), Nantes

Centre Antoine Lacassagne, Nice

Groupe Hospitalier Diaconesses Croix Saint Simon, Paris

Institut Curie - Site de Paris, Paris

Centre Hospitalier Annecy Genevois, Pringy

Centre Eugène Marquis, Rennes

Centre Henri Becquerel, Rouen

Clinique Pasteur, Toulouse

Institut Claudius Regaud, Toulouse

Inselspital Bern, Bern

University Hospital Geneva, Geneva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

ETOP IBCSG Partners Foundation

NETWORK

NCT03644186 - To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) | Biotech Hunter | Biotech Hunter